Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans

Recruiting Phase 1 Interventional Study
Major Depression Disorder Depression
Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 65
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Other
Participants needed
60 (estimated)
Sponsor
Deepak C. D'Souza · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this phase 1 study is to investigate the safety and efficacy of dimethyltryptamine (DMT) in individuals with depression and healthy controls. We hypothesize that administration of DMT will result in decreases in depression, associated symptoms, and neuroplastic changes in depressed subjects. We expect that DMT will induce changes in neuroplasticity as indexed using electroencephalograp…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Some Common Inclusion Criteria: 1. Males and females 2. Age 21 to 65 years 3. Body mass index between 18-35 kg/m2 4. Willing to refrain from taking any medications not approved by the study physician 5. Willing to refrain from using street drugs and alcohol 6. Negative urine drug screen 7. Willing …
Contacts

Deepak C D'Souza, MD

(203) 932-5711

deepak.dsouza@yale.edu

CONTACT